Download: RSS | Email Alerts | Text Alerts | Podcasts | Mobile

FDA flags psychiatric effects of asthma drugs

Federal health officials are requiring new labels on popular asthma drugs like Merck's Singulair that highlight language about suicidal behavior, depression and anxiousness seen in a small number of patients.

Click here to read the full story.

Post a Comment
Video Comments
No comments yet!
Comments
No comments yet!
Save/Share Story
Post on Facebook Follow us on Twitter



Ask our Doctor On Call

If you have a health related story suggestion or question for our Doctor On Call, email us at familyhealth@9wsyr.com please include a subject line with topic, and your contact information including city name.

We try to answer as many questions as we can, but due to overwhelming response, are not able to get to them all.

First Name
City/Town
Email Address if you want to be contacted.
Question
Incorrect please try again
Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help


  This site is hosted and managed by Inergize Digital.